Cancers 2013, 5(2), 591-616; doi:10.3390/cancers5020591

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

1,2,3,* email, 1,2,3,4email, 1,2,4email, 5email, 1,2,3,4email and 1,2,3,4email
Received: 22 March 2013; in revised form: 28 April 2013 / Accepted: 9 May 2013 / Published: 24 May 2013
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Osteosarcoma is the most frequent malignant primary bone tumor and a main cause of cancer-related death in children and adolescents. Although long-term survival in localized osteosarcoma has improved to about 60% during the 1960s and 1970s, long-term survival in both localized and metastatic osteosarcoma has stagnated in the past several decades. Thus, current conventional therapy consists of multi-agent chemotherapy, surgery and radiation, which is not fully adequate for osteosarcoma treatment. Innovative drugs and approaches are needed to further improve outcome in osteosarcoma patients. This review describes the current management of osteosarcoma as well as potential new therapies.
Keywords: osteosarcoma; chemotherapy; surgery; radiotherapy; multidisciplinary treatment; emerging drugs
PDF Full-text Download PDF Full-Text [470 KB, uploaded 24 May 2013 16:42 CEST]

Export to BibTeX |

MDPI and ACS Style

Ando, K.; Heymann, M.-F.; Stresing, V.; Mori, K.; Rédini, F.; Heymann, D. Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers 2013, 5, 591-616.

AMA Style

Ando K, Heymann M-F, Stresing V, Mori K, Rédini F, Heymann D. Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers. 2013; 5(2):591-616.

Chicago/Turabian Style

Ando, Kosei; Heymann, Marie-Françoise; Stresing, Verena; Mori, Kanji; Rédini, Françoise; Heymann, Dominique. 2013. "Current Therapeutic Strategies and Novel Approaches in Osteosarcoma." Cancers 5, no. 2: 591-616.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert